These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2265805)

  • 1. CA 125, placental alkaline phosphatase, and tissue polypeptide antigen in the monitoring of ovarian carcinoma. A comparative study of three different tumor markers.
    Hørding U; Toftager-Larsen K; Dreisler A; Lund B; Daugaard S; Lundvall F; Arends J; Winkel P; Rørth M
    Gynecol Obstet Invest; 1990; 30(3):178-83. PubMed ID: 2265805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental alkaline phosphatase (PLAP)/PLAP-like alkaline phosphatase as tumour marker in relation to CA 125 and TPA for ovarian epithelial tumours.
    Stigbrand T; Riklund K; Tholander B; Hirano K; Lalos O; Stendahl U
    Eur J Gynaecol Oncol; 1990; 11(5):351-60. PubMed ID: 2097151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma.
    Vergote IB; Abeler VM; Børmer OP; Stigbrand T; Tropé C; Nustad K
    Tumour Biol; 1992; 13(3):168-74. PubMed ID: 1626181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase, in patients with ovarian carcinoma, borderline tumors, or benign adnexal masses: relevance for differential diagnosis.
    Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Kiviranta A; Hallman K; Holm L; Weiner E; Tamsen L
    Gynecol Oncol; 1990 Oct; 39(1):16-25. PubMed ID: 2227569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment serum levels of CA-125, carcinoembryonic antigen, tissue polypeptide antigen, and placental alkaline phosphatase in patients with ovarian carcinoma: influence of histological type, grade of differentiation, and clinical stage of disease.
    Tholander B; Taube A; Lindgren A; Sjöberg O; Stendahl U; Tamsen L
    Gynecol Oncol; 1990 Oct; 39(1):26-33. PubMed ID: 2227570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CA-125, placental alkaline phosphatase and tissue polypeptide antigen as preoperative serum markers in ovarian carcinoma.
    Toftager-Larsen K; Hørding U; Dreisler A; Daugaard S; Lund B; Bock J; Lundvall F; Frederiksen K; Nørgaard-Pedersen B
    Gynecol Obstet Invest; 1992; 33(3):177-82. PubMed ID: 1319386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum placental-like alkaline phosphatase (PLAP): a novel combined enzyme linked immunoassay for monitoring ovarian cancer.
    Fisken J; Leonard RC; Shaw G; Bowman A; Roulston JE
    J Clin Pathol; 1989 Jan; 42(1):40-5. PubMed ID: 2921344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum placental alkaline phosphatase (PLAP) in gynecologic malignancies--with special reference to the combination of PLAP and CA54/61 assay.
    Nozawa S; Udagawa Y; Ohkura H; Negishi Y; Akiya K; Inaba N; Takamizawa H; Kimura E; Terashima Y
    Clin Chim Acta; 1990 Jan; 186(2):275-84. PubMed ID: 2178810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor markers in colorectal carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.
    Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
    Acta Radiol Oncol; 1984; 23(1):27-32. PubMed ID: 6328884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Independent expression in serum of three tumour-associated antigens: CA 125, placental alkaline phosphatase and HMFG2 in ovarian carcinoma.
    Ward BG; Cruickshank DJ; Tucker DF; Love S
    Br J Obstet Gynaecol; 1987 Jul; 94(7):696-8. PubMed ID: 2441739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of alkaline phosphatase isozymes in the monitoring of patients with colorectal carcinoma.
    Harmenberg U; Frödin JE; Ljungdahl-Stähle E; Mellstedt H; Wahren B; Stigbrand T
    Tumour Biol; 1989; 10(5):225-31. PubMed ID: 2814231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of CA 125 and placental alkaline phosphatase as ovarian tumor markers.
    Heinonen PK; Kallioniemi OP; Koivula T
    Tumori; 1987 Jun; 73(3):301-2. PubMed ID: 3474819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer antigen 125, tissue polypeptide antigen, carcinoembryonic antigen, and beta-chain human chorionic gonadotropin as serum markers of epithelial ovarian carcinoma.
    Panza N; Pacilio G; Campanella L; Peluso G; Battista C; Amoriello A; Utech W; Vacca C; Lombardi G
    Cancer; 1988 Jan; 61(1):76-83. PubMed ID: 2446734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate elevation of serum markers in ovarian cancer but not in benign disease.
    Bast RC; Knauf S; Epenetos A; Dhokia B; Daly L; Tanner M; Soper J; Creasman W; Gall S; Knapp RC
    Cancer; 1991 Oct; 68(8):1758-63. PubMed ID: 1913520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of seven tumor markers (CA 50, CA 19-9, CA 19-9 TruQuant, CA 72-4, CA 195, carcinoembryonic antigen, and tissue polypeptide antigen) in the pretreatment sera of patients with gastric carcinoma.
    Wobbes T; Thomas CM; Segers MF; Nagengast FM
    Cancer; 1992 Apr; 69(8):2036-41. PubMed ID: 1544112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catalytic and immunologic activities of placental-like alkaline phosphatase in clinical studies. The value of PLAP in follow-up of ovarian cancer.
    Haije WG; van Driel J; van der Burg ME
    Clin Chim Acta; 1987 Jun; 165(2-3):165-75. PubMed ID: 2443278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative determination of several serum tumor markers in patients with primary epithelial ovarian carcinoma.
    Kudoh K; Kikuchi Y; Kita T; Tode T; Takano M; Hirata J; Mano Y; Yamamoto K; Nagata I
    Gynecol Obstet Invest; 1999; 47(1):52-7. PubMed ID: 9852392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor markers in bronchogenic carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphatase and pseudouridine.
    Rasmuson T; Björk GR; Damber L; Holm SE; Jacobsson L; Jeppsson A; Stigbrand T; Westman G
    Acta Radiol Oncol; 1983; 22(3):209-14. PubMed ID: 6312760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological markers and ovarian carcinomas: galactosyltransferase, CA 125, isoenzymes of amylase and alkaline phosphatase.
    Sichel F; Salaün V; Bar E; Gauduchon P; Malas JP; Goussard J; Le Talaër JY
    Clin Chim Acta; 1994 Jun; 227(1-2):87-96. PubMed ID: 7525119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The concomitant determination of different serum tumor markers in epithelial ovarian cancer: relevance for monitoring the response to chemotherapy and follow-up of patients.
    Fioretti P; Gadducci A; Ferdeghini M; Prontera C; Malagnino G; Facchini V; Mariani G; Bianchi R
    Gynecol Oncol; 1992 Feb; 44(2):155-60. PubMed ID: 1544592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.